BPC-157 may be a good fit for patients dealing with joint pain, gut health concerns, slow recovery from physical activity, or inflammation that is interfering with their weight loss progress
Only two small pilot studies have been done on humans thus far
Convergence with Combination Biology Dual and multi-agonist molecules combining GLP-1 activity with GIP and/or glucagon receptor activity are emerging and driving superior metabolic efficacy in clinical studies
Originally designed by the ham radio industry for their 12V DC standard connector, they were quickly adopted in the radio control community
Patients reported nausea, diarrhea, and mild heart rate increases early in treatment
Add a GLP-1 medication that further slows gastric emptying, and you have a recipe for extended fermentation and increased gas production